The Rise of Injectable Drugs

From weight-loss drugs like Wegovy to cholesterol-lowering Leqvio, injectable drugs are reshaping modern medicine—with new risks and higher costs.
Injectables are already an $800 billion a year market.
One popular injectable costs $70,000 a year.
Today, a growing number of new medications are being delivered via injection rather than as oral pills. It’s a trend driven by advancements in biotechnology, the idea that it’s easier for patients, and pharmaceutical industry profits. But what are the trade-offs when it comes to cost and safety, and what does it mean for patients and the industry?

In this episode George discusses the new trend in injectable drugs and their effect on the medical market.